Prof. Dr. Andreas Mackensen

Lehrstuhl für Innere Medizin V

Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD (2025) Habenicht K, Wanzek J, Bootz A, Schäfer S, Vollmer L, Hiergeist A, Fante M, et al. Journal article Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT (2025) Flamann C, Shaikh H, Matos C, Kreutz M, Ali H, Kern MA, Büttner-Herold M, et al. Journal article CAR-T-Zellen bei nicht-malignen Erkrankungen (2025) Müller F, Hagen M, Schett G, Mackensen A Journal article Effects of different B-cell-depleting strategies on the lymphatic tissue (2025) Tur C, Eckstein M, Bucci L, Auth J, Bergmann C, Rauber S, Hagen M, et al. Journal article Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma (2025) Müller F, Schwingen NR, Hagen M, Scholz JK, Aigner M, Wirsching A, Taubmann J, et al. Journal article Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells (2024) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Aigner M, Völkl S, et al. Journal article CD19-CAR T-cell therapy induces deep tissue depletion of B cells (2024) Tur C, Eckstein M, Velden J, Rauber S, Bergmann C, Auth J, Bucci L, et al. Journal article The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany (2024) Krebs M, Haller F, Spörl S, Gerhard-Hartmann E, Utpatel K, Maurus K, Kunzmann V, et al. Journal article CAR T-cell perspectives in lupus – Authors' reply (2024) Schett G, Mackensen A, Mougiakakos D Journal article Selective CAR T cell–mediated B cell depletion suppresses IFN signature in SLE (2024) Wilhelm A, Chambers D, Müller F, Bozec A, Grieshaber Bouyer R, Winkler T, Mougiakakos D, et al. Journal article